Delivery Order SPE2DR25D3004-SPE2DR26FXPD6
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $20,650.18 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,131.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable rheumatoid arthritis medication. This firm fixed price, non-set-aside delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,950.67 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and was not subject to a set-aside designation. The contract was issued from AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $10,721.34 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a rheumatoid arthritis and autoimmune disease medication. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, under a firm fixed price arrangement. This delivery order is a non-set-aside competitive award issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,593.72 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for treating autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mls, a pharmaceutical product for treating autoimmune conditions. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, utilizes firm fixed pricing with no set-aside designation, indicating the award was made through open competition. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $1,510.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, an immunosuppressant medication used to treat autoimmune diseases. This firm fixed-price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a single-transaction purchase under a larger contract vehicle. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,775.88 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...